ArticleFrontiers in immunology2026
Detection of RBC-bound antibodies using flow cytometry and their correlation with HLA polymorphism.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The immune response in elderly individuals is influenced by genetic factors, particularly polymorphisms in major histocompatibility complex (MHC), such as human leukocyte antigen (HLA). Age-related changes in immune function, referred to as immunosenescence, can lead to the formation of RBC-bound antibodies, which may pose risks in transfusion medicine. Objective: This study aims to investigate the association between HLA-DQB1 alleles and the presence of RBC-bound antibodies in elderly individuals. Materials and methods: A total of 83 healthy elderly (aged 60-70) samples were collected. Blood samples were processed by centrifugation at 3500 rpm for 10 min to obtain serum. RBCs were isolated through centrifugation at 3000 rpm, washed with saline, and 2% type O RBC was prepared. Serum (100 µL) was mixed with saline (100 µL) and 2% type O RBCs (50 µL), incubated at 37 °C for 30 min, and analyzed via flow cytometry. At the same time, control sample was also processed with equal volume. DNA was extracted using the sequence-based typing kit, and specific genes at the HLA DQB1 locus were amplified by PCR, confirmed through agarose gel electrophoresis and sequencing for allele identification. Results: RBC-bound antibodies were detected in 42 of 83 participants, indicating a higher index of agglutination (IAG), while 41 samples showed no RBC-bound antibodies, indicating negative IAG. The mean IAG was Conclusion: This study highlights the role of HLA-DQB1
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.